Second Annual $500,000 XSeed Award Launched by Deerfield Management to Support Underfunded and Underrepresented NYC Life Science Startups

Cure Membership CTA to Circle Article Body

Cure Membership CTA to Circle Right Rail

A look at 13 startups and public companies advancing genetic medicines, cell-based therapies, and next-generation treatment platforms.

13 Cell and Gene Therapy Companies to Watch in 2026

Brianne Kimmel is redefining how women’s health gets funded. As founder and managing partner of WorkLife Ventures, she invests in female-led startups focused on making care more accessible, affordable, and aligned with women’s real-life needs.

Brianne Kimmel on Backing Female Founders Reshaping Women’s Health

A look at 11 companies using AI-driven platforms to reshape drug discovery, including generative models, computational chemistry, and data-centric biology.

11 Innovative Companies Using AI for Drug Discovery

Nell Smircina of Novastone Capital Advisors, and Tierney Saccavino-Payne of TSP Communications answer questions that are always top-of-mind for founders: from communicating setbacks to planning a raise.

Biotech Investor Relations Experts Answer Founders’ Most Asked Questions

345 Park Avenue South

Cure by Deerfield Launches Middle East Health Accelerator in Qatar Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Become a Member

X Factor: Healthcare Innovation Summit

Thumbnail Events Mega Menu Highlight - X Factor Image

Patient Engagement Is the Secret to Smarter Research—Here’s How to Nail It

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Your Home in NYC

Featured Event

X Factor: Healthcare Innovation Summit

Accelerating Advances in Health

Second Annual $500,000 XSeed Award Launched by Deerfield Management to Support Underfunded and Underrepresented NYC Life Science Startups

More Stories